A Comparison of Peak Sputum Tobramycin Concentration in Patients With Cystic Fibrosis Using Jet and Ultrasonic Nebulizer Systems
- 1 April 1997
- Vol. 111 (4) , 955-962
- https://doi.org/10.1378/chest.111.4.955
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Identification of the Cystic Fibrosis Gene: Genetic AnalysisScience, 1989
- Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosisPediatric Pulmonology, 1989
- A controlled trial of nebulized aminoglycoside and oral flucloxacillin versus placebo in the outpatient management of children with cystic fibrosisRespiratory Medicine, 1987
- Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosaRespiratory Medicine, 1987
- Inhaled antibiotics in cystic fibrosis: Is there a therapeutic effect?The Journal of Pediatrics, 1986
- Bioactivity of Gentamicin in Purulent Sputum from Patients with Cystic Fibrosis or Bronchiectasis: Comparison with Activity in SerumThe Journal of Infectious Diseases, 1983
- INHALED ANTIBIOTICS IN CYSTIC FIBROSISThe Lancet, 1983
- AEROSOL CARBENICILLIN AND GENTAMICIN TREATMENT OF PSEUDOMONAS AERUGINOSA INFECTION IN PATIENTS WITH CYSTIC FIBROSISThe Lancet, 1981
- Penetration of Antibiotics into Respiratory SecretionsClinical Infectious Diseases, 1981
- Drug-induced OtotoxicityDrugs, 1980